# Ultragenyx Pharmaceutical Inc.: Form 8-K, filed Feb 3, 2026

- Company: [Ultragenyx Pharmaceutical Inc.](/companies/rare.md) (CIK 1515673)
- Form: 8-K
- Filed: 2026-02-03
- Accepted by EDGAR: Feb 3, 2026, 08:15 ET
- Period: 2026-02-03
- Accession: 0001193125-26-034474
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1515673/000119312526034474/rare-20260203.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1515673/000119312526034474/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1515673/000119312526034474/rare-20260203.htm

Filed Feb 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-034474. Last ingested by Listed: Nov 14, 2026, 11:37 ET. No prices; not investment advice.